| Pulmonary artery hypertension is a chronic disease associated with poor prognosis and a 5-year survival rate of about 50–60%. |
| Current treatments improve the prognosis, but they do not arrest the progression of disease and they are associated with significant adverse effects. |
| There is an immediate need for new clinical trials involving new drugs with enhanced efficacy and milder adverse effects. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.